State Street Portfolio holdings
State Street Corporation, established in 1792 and headquartered in Boston, Massachusetts, is one of the oldest financial institutions in the United States and a major player in the global asset management and custody banking sectors. Primarily known for its custodial services, it safeguards assets for institutional investors, managing trillions of dollars through its State Street Global Advisors (SSGA) division, which is renowned for launching the first U.S. exchange-traded fund (ETF), the SPDR S&P 500 ETF (SPY), in 1993. The company provides a range of services including investment management, research, trading, and data analytics, catering mostly to institutional clients like pension funds, endowments, and mutual funds. With a focus on financial infrastructure and innovation, State Street has positioned itself as a key backbone in the global investment ecosystem.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.45B |
| 2 |
Analog Devices
ADI
|
+$1.37B |
| 3 |
Amazon
AMZN
|
+$1.24B |
| 4 |
Tesla
TSLA
|
+$989M |
| 5 |
Match Group
MTCH
|
+$950M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$1.84B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$1.43B |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$629M |
| 4 |
WORK
Slack Technologies, Inc.
WORK
|
+$528M |
| 5 |
Oracle
ORCL
|
+$440M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.19% |
| 2 | Financials | 14.6% |
| 3 | Healthcare | 13.28% |
| 4 | Consumer Discretionary | 11.11% |
| 5 | Industrials | 9.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1601
Spectrum Brands
SPB
$2.07B
| $65.1M | ﹤0.01% |
680,151
-6,182
| -0.9% | -$525K |
|
1602
Armstrong World Industries
AWI
$7.84B
| $65M | ﹤0.01% |
681,345
-2,315
| -0.3% | -$243K |
|
1603
Materion
MTRN
$6.04B
| $64.8M | ﹤0.01% |
944,759
-180,202
| -16% | -$12.9M |
|
1604
Coherus Oncology
CHRS
$196M
| $64.8M | ﹤0.01% |
4,033,706
-1,040,435
| -21% | -$15.3M |
|
|
CVSA
1605
Covista Inc
CVSA
$4.8B
| $64.7M | ﹤0.01% |
1,712,121
+150,305
| +10% | +$5.58M |
|
|
AGEN
1606
Agenus
AGEN
$290M
| $64.6M | ﹤0.01% |
627,348
+66,040
| +12% | +$7.46M |
|
1607
TechTarget
TTGT
$278M
| $64.6M | ﹤0.01% |
784,279
+31,870
| +4% | +$2.53M |
|
1608
Corcept Therapeutics
CORT
$12B
| $64.4M | ﹤0.01% |
3,272,743
-9,129
| -0.3% | -$191K |
|
|
CVET
1609
DELISTED
Covetrus, Inc. Common Stock
CVET
| $64.4M | ﹤0.01% |
3,550,303
+80,242
| +2% | +$1.84M |
|
|
BBBY
1610
DELISTED
Bed Bath & Beyond Inc
BBBY
| $64.1M | ﹤0.01% |
3,713,192
-93,612
| -2% | -$2.53M |
|
|
SAFE
1611
Safehold
SAFE
$1.15B
| $64.1M | ﹤0.01% |
525,195
-8,671
| -2% | -$1.05M |
|
|
DQ
1612
Daqo New Energy
DQ
$996M
| $64.1M | ﹤0.01% |
1,124,269
+58,045
| +5% | +$3.47M |
|
1613
NETSCOUT
NTCT
$2.79B
| $64M | ﹤0.01% |
2,376,066
-48,361
| -2% | -$1.34M |
|
1614
iShares MSCI EAFE Small-Cap ETF
SCZ
$13.7B
| $64M | ﹤0.01% |
859,547
-38,533
| -4% | -$2.93M |
|
|
CERE
1615
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
| $63.8M | ﹤0.01% |
2,161,772
+852,253
| +65% | +$23.9M |
|
1616
ALX Oncology
ALXO
$290M
| $63.6M | ﹤0.01% |
861,555
-193,322
| -18% | -$12.9M |
|
1617
Pricesmart
PSMT
$5.46B
| $63.5M | ﹤0.01% |
819,143
-44,258
| -5% | -$3.76M |
|
|
WWE
1618
DELISTED
World Wrestling Entertainment
WWE
| $63.3M | ﹤0.01% |
1,124,625
-10,554
| -0.9% | -$550K |
|
1619
Northwest Bancshares
NWBI
$2.28B
| $63.2M | ﹤0.01% |
4,762,595
-35,240
| -0.7% | -$463K |
|
1620
Nu Skin
NUS
$267M
| $63.1M | ﹤0.01% |
1,559,878
-60,584
| -4% | -$3.07M |
|
|
ALTR
1621
DELISTED
Altair Engineering Inc
ALTR
| $63M | ﹤0.01% |
913,811
+6,458
| +0.7% | +$461K |
|
1622
Healthcare Services Group
HCSG
$1.53B
| $62.9M | ﹤0.01% |
2,518,825
+264,131
| +12% | +$7.14M |
|
|
VMEO
1623
DELISTED
Vimeo
VMEO
| $62.9M | ﹤0.01% |
2,142,565
+70,020
| +3% | +$2.76M |
|
|
RETA
1624
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $62.8M | ﹤0.01% |
623,956
+34,467
| +6% | +$4.04M |
|
1625
CryoPort
CYRX
$762M
| $62.6M | ﹤0.01% |
940,720
-7,552
| -0.8% | -$466K |
|
Similar funds
State Street's Q3 2021 Portfolio in Review
As of Q3 2021, State Street held 4,773 positions worth $1.89T, down 0.28% from $1.9T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
State Street's Q3 2021 filing shows 298 new, 2,370 increased, 1,521 reduced and 88 closed positions. Its largest new stake was GXO Logistics: 2,520,396 shares worth $198M. The largest sale was Alexion Pharmaceuticals, an estimated $1.84B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- State Street's largest Q3 2021 buy was GXO Logistics: 2,520,396 shares worth $198M.
- State Street added most to Moderna in Q3 2021, an estimated $2.45B increase.
- State Street's biggest Q3 2021 reduction was Berkshire Hathaway Class B, cutting an estimated $629M.
- State Street fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $1.84B.
- State Street's ten largest holdings make up 21% of its $1.89T portfolio in Q3 2021.
- State Street opened 298 new positions and closed 88 in Q3 2021.
- State Street's portfolio value fell 0.28% quarter-over-quarter to $1.89T.
Based on State Street's 13F filing for Q3 2021, filed 15 Nov 2021.